Addiction, ISSN 0965-2140, 09/2018, Volume 113, Issue 9, pp. 1716 - 1726
Background and aims Tuberculosis (TB) patients who quit smoking have much better disease outcomes than those who continue to smoke. In general populations,...
Bangladesh | placebo‐controlled randomized trial | tobacco cessation | Pakistan | low‐ and‐middle income countries | smoking cessation | tuberculosis | cytisine | low- and-middle income countries | placebo-controlled randomized trial | Clinical trials | Medicine, Experimental | Smoking cessation programs | Medical research | Tuberculosis | Chewing tobacco | Health care | Drug addiction | Pharmacology | Smoke | Patients | Smoking cessation | Tobacco | Randomization | Safety engineering | Dependence | Safety | Public health | Smoking | Nicotine | Trial Protocol
Bangladesh | placebo‐controlled randomized trial | tobacco cessation | Pakistan | low‐ and‐middle income countries | smoking cessation | tuberculosis | cytisine | low- and-middle income countries | placebo-controlled randomized trial | Clinical trials | Medicine, Experimental | Smoking cessation programs | Medical research | Tuberculosis | Chewing tobacco | Health care | Drug addiction | Pharmacology | Smoke | Patients | Smoking cessation | Tobacco | Randomization | Safety engineering | Dependence | Safety | Public health | Smoking | Nicotine | Trial Protocol
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 2015, Volume 117, Issue 2, pp. 229 - 233
Abstract Purpose To report the efficacy of Hydrosorb® versus control (water based spray) as topical treatment of grade 1–2 radiodermatitis in patients (pts)...
Hematology, Oncology and Palliative Medicine | Radiodermatitis | Breast cancer | Controlled randomized trial | Hydrosorb | Hydrosorb (R) | PREVENTION | HYALURONIC-ACID | RADIATION-THERAPY | PHASE-III TRIAL | BREAST-CANCER | IRRADIATION | ALOE-VERA GEL | ONCOLOGY | RADIOTHERAPY | HELICAL TOMOTHERAPY | PROPHYLACTIC AGENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Water | Prospective Studies | Polyesters - therapeutic use | Humans | Middle Aged | Dermatologic Agents - therapeutic use | Radiotherapy - adverse effects | Young Adult | Breast Neoplasms - radiotherapy | Aged, 80 and over | Quality of Life | Adult | Female | Aged | Radiodermatitis - drug therapy | Administration, Topical | Radiodermatitis - etiology | Skin
Hematology, Oncology and Palliative Medicine | Radiodermatitis | Breast cancer | Controlled randomized trial | Hydrosorb | Hydrosorb (R) | PREVENTION | HYALURONIC-ACID | RADIATION-THERAPY | PHASE-III TRIAL | BREAST-CANCER | IRRADIATION | ALOE-VERA GEL | ONCOLOGY | RADIOTHERAPY | HELICAL TOMOTHERAPY | PROPHYLACTIC AGENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Water | Prospective Studies | Polyesters - therapeutic use | Humans | Middle Aged | Dermatologic Agents - therapeutic use | Radiotherapy - adverse effects | Young Adult | Breast Neoplasms - radiotherapy | Aged, 80 and over | Quality of Life | Adult | Female | Aged | Radiodermatitis - drug therapy | Administration, Topical | Radiodermatitis - etiology | Skin
Journal Article
Spine, ISSN 0362-2436, 12/2011, Volume 36, Issue 26, pp. 2235 - 2242
Randomized parallel group comparative trial with a 1-year follow-up period. To compare in a population of patients with chronic low back pain, the...
functional restoration | controlled randomized trial | physical therapy | low back pain | occupational therapy | Exercise Therapy - methods | Chronic Pain - therapy | Lost to Follow-Up | Follow-Up Studies | Humans | Middle Aged | Sick Leave - statistics & numerical data | Male | Treatment Outcome | Low Back Pain - therapy | Young Adult | Interdisciplinary Studies | Low Back Pain - physiopathology | Time Factors | Psychotherapy - methods | Physical Therapy Modalities | Recovery of Function - physiology | Adult | Female | Chronic Pain - physiopathology | Pain Measurement
functional restoration | controlled randomized trial | physical therapy | low back pain | occupational therapy | Exercise Therapy - methods | Chronic Pain - therapy | Lost to Follow-Up | Follow-Up Studies | Humans | Middle Aged | Sick Leave - statistics & numerical data | Male | Treatment Outcome | Low Back Pain - therapy | Young Adult | Interdisciplinary Studies | Low Back Pain - physiopathology | Time Factors | Psychotherapy - methods | Physical Therapy Modalities | Recovery of Function - physiology | Adult | Female | Chronic Pain - physiopathology | Pain Measurement
Journal Article
European Journal of Neurology, ISSN 1351-5101, 05/2009, Volume 16, Issue 5, pp. 631 - 638
Background and purpose: For treatment of multifocal motor neuropathy (MMN), we hypothesized that (i) infusion of equivalent dosages of subcutaneous...
controlled randomized trial | multifocal motor neuropathy | chronic inflammatory demyelinating polyradiculoneuropathy | intravenous immunoglobulin | subcutaneous immunoglobulin | Intravenous immunoglobulin | Multifocal motor neuropathy | Subcutaneous immunoglobulin | Controlled randomized trial | Chronic inflammatory demyelinating polyradiculoneuropathy | PRIMARY ANTIBODY DEFICIENCIES | CRITERIA | CLINICAL-TRIAL | IMMUNE GLOBULIN | STRENGTH | NEUROSCIENCES | CLINICAL NEUROLOGY | REPLACEMENT | IGG SELF-INFUSIONS | QUALITY-OF-LIFE | POLYNEUROPATHIES | HOME | Single-Blind Method | Recovery of Function - drug effects | Humans | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Electrophysiology | Male | Polyneuropathies - drug therapy | Immunoglobulins - administration & dosage | Infusions, Subcutaneous | Patient Satisfaction | Cross-Over Studies | Immunoglobulins - adverse effects | Quality of Life | Adult | Female | Muscle Strength - drug effects | Clinical trials | Immunoglobulins
controlled randomized trial | multifocal motor neuropathy | chronic inflammatory demyelinating polyradiculoneuropathy | intravenous immunoglobulin | subcutaneous immunoglobulin | Intravenous immunoglobulin | Multifocal motor neuropathy | Subcutaneous immunoglobulin | Controlled randomized trial | Chronic inflammatory demyelinating polyradiculoneuropathy | PRIMARY ANTIBODY DEFICIENCIES | CRITERIA | CLINICAL-TRIAL | IMMUNE GLOBULIN | STRENGTH | NEUROSCIENCES | CLINICAL NEUROLOGY | REPLACEMENT | IGG SELF-INFUSIONS | QUALITY-OF-LIFE | POLYNEUROPATHIES | HOME | Single-Blind Method | Recovery of Function - drug effects | Humans | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Electrophysiology | Male | Polyneuropathies - drug therapy | Immunoglobulins - administration & dosage | Infusions, Subcutaneous | Patient Satisfaction | Cross-Over Studies | Immunoglobulins - adverse effects | Quality of Life | Adult | Female | Muscle Strength - drug effects | Clinical trials | Immunoglobulins
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2016, Volume 106, Issue 7, pp. 1807 - 1814
Objective To evaluate the efficacy and safety of an ultra-low-dose oral contraceptive (NPC-01; 0.02 mg ethinyl estradiol and 1 mg norethisterone) in subjects...
Internal Medicine | Obstetrics and Gynecology | Ultra-low-dose oral contraceptives | dysmenorrhea | placebo-controlled randomized trial | PATHOGENESIS | REPRODUCTIVE BIOLOGY | MANAGEMENT | REGIMEN | RECURRENCE | PILL | YOUNG-WOMEN | ENDOMETRIOSIS | OBSTETRICS & GYNECOLOGY | Analgesics - therapeutic use | Contraceptives, Oral, Hormonal - adverse effects | Work Capacity Evaluation | Double-Blind Method | Administration, Oral | Dysmenorrhea - drug therapy | Humans | Japan | Contraceptives, Oral, Hormonal - administration & dosage | Treatment Outcome | Norethindrone - administration & dosage | Contraceptives, Oral, Combined - adverse effects | Young Adult | Dysmenorrhea - physiopathology | Ethinyl Estradiol - adverse effects | Time Factors | Norethindrone - adverse effects | Adult | Female | Dysmenorrhea - diagnosis | Ethinyl Estradiol - administration & dosage | Menstrual Cycle - drug effects | Contraceptives, Oral, Combined - administration & dosage | Pain Measurement | Norethindrone | Medical colleges | Analysis | Clinical trials | Ethinyl estradiol | Dosage and administration | Oral contraceptives | Estradiol | Dysmenorrhea
Internal Medicine | Obstetrics and Gynecology | Ultra-low-dose oral contraceptives | dysmenorrhea | placebo-controlled randomized trial | PATHOGENESIS | REPRODUCTIVE BIOLOGY | MANAGEMENT | REGIMEN | RECURRENCE | PILL | YOUNG-WOMEN | ENDOMETRIOSIS | OBSTETRICS & GYNECOLOGY | Analgesics - therapeutic use | Contraceptives, Oral, Hormonal - adverse effects | Work Capacity Evaluation | Double-Blind Method | Administration, Oral | Dysmenorrhea - drug therapy | Humans | Japan | Contraceptives, Oral, Hormonal - administration & dosage | Treatment Outcome | Norethindrone - administration & dosage | Contraceptives, Oral, Combined - adverse effects | Young Adult | Dysmenorrhea - physiopathology | Ethinyl Estradiol - adverse effects | Time Factors | Norethindrone - adverse effects | Adult | Female | Dysmenorrhea - diagnosis | Ethinyl Estradiol - administration & dosage | Menstrual Cycle - drug effects | Contraceptives, Oral, Combined - administration & dosage | Pain Measurement | Norethindrone | Medical colleges | Analysis | Clinical trials | Ethinyl estradiol | Dosage and administration | Oral contraceptives | Estradiol | Dysmenorrhea
Journal Article
Journal of Clinical Rheumatology, ISSN 1076-1608, 09/2013, Volume 19, Issue 6, pp. 308 - 316
BACKGROUNDKnee osteoarthritis is a chronic disease associated with significant morbidity and economic cost. The efficacy of acupuncture in addition to...
CHRONIC PAIN | RHEUMATOLOGY | ALTERNATIVE MEDICINE | COMPLEMENTARY | acupuncture | RECOMMENDATIONS | osteoarthritis of the knee | physical therapy | PATIENT | CLINICAL IMPORTANCE | OUTCOMES | obese patients | EXPECTATIONS | placebo-controlled randomized trial | African American | Body Mass Index | Prospective Studies | Double-Blind Method | Humans | Middle Aged | Logistic Models | Male | Treatment Outcome | Combined Modality Therapy | Osteoarthritis, Knee - therapy | Acupuncture Therapy | European Continental Ancestry Group - ethnology | Osteoarthritis, Knee - ethnology | Exercise Therapy | African Americans - ethnology | Female | Aged | Pain Measurement | Randomized clinical trial | Non-puncturing needle | Osteoarthritis of the knee | placebo controlled | Acupuncture
CHRONIC PAIN | RHEUMATOLOGY | ALTERNATIVE MEDICINE | COMPLEMENTARY | acupuncture | RECOMMENDATIONS | osteoarthritis of the knee | physical therapy | PATIENT | CLINICAL IMPORTANCE | OUTCOMES | obese patients | EXPECTATIONS | placebo-controlled randomized trial | African American | Body Mass Index | Prospective Studies | Double-Blind Method | Humans | Middle Aged | Logistic Models | Male | Treatment Outcome | Combined Modality Therapy | Osteoarthritis, Knee - therapy | Acupuncture Therapy | European Continental Ancestry Group - ethnology | Osteoarthritis, Knee - ethnology | Exercise Therapy | African Americans - ethnology | Female | Aged | Pain Measurement | Randomized clinical trial | Non-puncturing needle | Osteoarthritis of the knee | placebo controlled | Acupuncture
Journal Article
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, ISSN 1530-4515, 04/2014, Volume 24, Issue 2, pp. 118 - 121
The value of fast-track (FT) multimodal recovery programs in improving hospitalization of surgical patients has been widely proved. The application of FT...
laparoscopy | high anterior resection | colorectal surgery | left hemicolectomy | prospective controlled randomized study | fast-track | SURGERY | RECOVERY | COLONIC SURGERY | CONVENTIONAL CARE | OUTCOMES | CANCER | Length of Stay | Prospective Studies | Pain, Postoperative - therapy | Humans | Middle Aged | Colectomy - methods | Gastrointestinal Motility - physiology | Male | Treatment Outcome | Laparoscopy | Colectomy - rehabilitation | Aged, 80 and over | Adult | Female | Aged | Rectum - surgery
laparoscopy | high anterior resection | colorectal surgery | left hemicolectomy | prospective controlled randomized study | fast-track | SURGERY | RECOVERY | COLONIC SURGERY | CONVENTIONAL CARE | OUTCOMES | CANCER | Length of Stay | Prospective Studies | Pain, Postoperative - therapy | Humans | Middle Aged | Colectomy - methods | Gastrointestinal Motility - physiology | Male | Treatment Outcome | Laparoscopy | Colectomy - rehabilitation | Aged, 80 and over | Adult | Female | Aged | Rectum - surgery
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 12/2008, Volume 10, Issue 12, pp. 1255 - 1263
Background: Crataegus preparations have been used for centuries especially in Europe. To date, no proper data on their efficacy and safety as an...
Efficacy | Crataegus extract WS® 1442 | Congestive heart failure | Safety | Survival | Controlled randomised trial | MORTALITY | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | Crataegus extract WS (R) 1442 | CONTRACTION | MORBIDITY | CLINICAL-TRIALS | DIGOXIN | SUDDEN CARDIAC DEATH | HAWTHORN EXTRACT | ENALAPRIL | Confidence Intervals | Double-Blind Method | Cardiac Output - drug effects | Humans | Middle Aged | Ventricular Function, Left - drug effects | Heart Failure - physiopathology | Stroke Volume - drug effects | Death, Sudden, Cardiac - prevention & control | Male | Exercise Tolerance - drug effects | Heart Failure - drug therapy | Heart Rate - drug effects | Survival Analysis | Female | Crataegus - adverse effects | Phytotherapy | Plant Extracts - therapeutic use | Heart Failure - mortality | Plant Extracts - adverse effects
Efficacy | Crataegus extract WS® 1442 | Congestive heart failure | Safety | Survival | Controlled randomised trial | MORTALITY | DESIGN | CARDIAC & CARDIOVASCULAR SYSTEMS | Crataegus extract WS (R) 1442 | CONTRACTION | MORBIDITY | CLINICAL-TRIALS | DIGOXIN | SUDDEN CARDIAC DEATH | HAWTHORN EXTRACT | ENALAPRIL | Confidence Intervals | Double-Blind Method | Cardiac Output - drug effects | Humans | Middle Aged | Ventricular Function, Left - drug effects | Heart Failure - physiopathology | Stroke Volume - drug effects | Death, Sudden, Cardiac - prevention & control | Male | Exercise Tolerance - drug effects | Heart Failure - drug therapy | Heart Rate - drug effects | Survival Analysis | Female | Crataegus - adverse effects | Phytotherapy | Plant Extracts - therapeutic use | Heart Failure - mortality | Plant Extracts - adverse effects
Journal Article
Addiction, ISSN 0965-2140, 09/2018, Volume 113, Issue 9, pp. 1716 - 1726
Background and aims Tuberculosis (TB) patients who quit smoking have much better disease outcomes than those who continue to smoke. In general populations,...
CRITERIA | METAANALYSIS | NICOTINE | low- and-middle income countries | tuberculosis | COMPONENTS | SYMPTOMS | cytisine | CESSATION | Bangladesh | tobacco cessation | Pakistan | smoking cessation | PULMONARY TUBERCULOSIS | TOBACCO-SMOKE | placebo-controlled randomized trial | WITHDRAWAL | PSYCHIATRY | SUBSTANCE ABUSE | TBSCORE
CRITERIA | METAANALYSIS | NICOTINE | low- and-middle income countries | tuberculosis | COMPONENTS | SYMPTOMS | cytisine | CESSATION | Bangladesh | tobacco cessation | Pakistan | smoking cessation | PULMONARY TUBERCULOSIS | TOBACCO-SMOKE | placebo-controlled randomized trial | WITHDRAWAL | PSYCHIATRY | SUBSTANCE ABUSE | TBSCORE
Journal Article
Pain, ISSN 0304-3959, 2003, Volume 103, Issue 3, pp. 277 - 283
Phantom limb pain (PLP) associated neuroplastic changes are partly mediated by excitatory amino acids at NMDA receptor sites. This study was undertaken to...
Memantine | Placebo-controlled randomized trial | Phantom limb pain | N-Methyl- d-aspartate receptor antagonist | N-Methyl-D-aspartate receptor antagonist | memantine | CORTICAL REORGANIZATION | N-methyl-D-aspartate receptor antagonist | NEUROSCIENCES | RAT MODEL | CLINICAL NEUROLOGY | NEUROPATHIC PAIN | HUMAN MOTOR CORTEX | DEXTROMETHORPHAN | ORAL KETAMINE | NOCICEPTIVE NEURONS | POSTHERPETIC NEURALGIA | DIABETIC NEUROPATHY | ANESTHESIOLOGY | HYPERALGESIA | phantom limb pain | placebo-controlled randomized trial | Phantom Limb - blood | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Excitatory Amino Acid Antagonists - therapeutic use | Demography | Double-Blind Method | Follow-Up Studies | Pain, Postoperative - drug therapy | Phantom Limb - drug therapy | Humans | Middle Aged | Memantine - blood | Male | Treatment Outcome | Excitatory Amino Acid Antagonists - blood | Adult | Female | Aged | Memantine - therapeutic use | Pain Measurement | Chronic Disease
Memantine | Placebo-controlled randomized trial | Phantom limb pain | N-Methyl- d-aspartate receptor antagonist | N-Methyl-D-aspartate receptor antagonist | memantine | CORTICAL REORGANIZATION | N-methyl-D-aspartate receptor antagonist | NEUROSCIENCES | RAT MODEL | CLINICAL NEUROLOGY | NEUROPATHIC PAIN | HUMAN MOTOR CORTEX | DEXTROMETHORPHAN | ORAL KETAMINE | NOCICEPTIVE NEURONS | POSTHERPETIC NEURALGIA | DIABETIC NEUROPATHY | ANESTHESIOLOGY | HYPERALGESIA | phantom limb pain | placebo-controlled randomized trial | Phantom Limb - blood | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Excitatory Amino Acid Antagonists - therapeutic use | Demography | Double-Blind Method | Follow-Up Studies | Pain, Postoperative - drug therapy | Phantom Limb - drug therapy | Humans | Middle Aged | Memantine - blood | Male | Treatment Outcome | Excitatory Amino Acid Antagonists - blood | Adult | Female | Aged | Memantine - therapeutic use | Pain Measurement | Chronic Disease
Journal Article
International Journal of Geriatric Psychiatry, ISSN 0885-6230, 12/2017, Volume 32, Issue 12, pp. e116 - e122
Objective The present investigation was intended to test the hypothesis that the elderly provided with the frequent consumption of fishes marinated in...
controlled randomized trial | frequent fish consumption | depression | elderly | perilla | METAANALYSIS | PSYCHIATRY | OMEGA-3-FATTY-ACIDS | GERIATRICS & GERONTOLOGY | SUPPLEMENTATION | WOMEN | COMMUNITY | N-3 | DOUBLE-BLIND | GERONTOLOGY | POLYUNSATURATED FATTY-ACIDS | PLACEBO-CONTROLLED TRIAL | ASSOCIATION | Humans | Middle Aged | Male | Perilla frutescens | Oils, Volatile - therapeutic use | Psychiatric Status Rating Scales | Animals | Iran | Fishes | Adult | Depressive Disorder - therapy | Diet Therapy - methods | Female | Aged | Plant Extracts - therapeutic use | Fish as food | Fatty acids | Depression, Mental | Statistical analysis | Mental disorders | Essential oils | Fish | Mental depression | Health risk assessment | Geriatrics
controlled randomized trial | frequent fish consumption | depression | elderly | perilla | METAANALYSIS | PSYCHIATRY | OMEGA-3-FATTY-ACIDS | GERIATRICS & GERONTOLOGY | SUPPLEMENTATION | WOMEN | COMMUNITY | N-3 | DOUBLE-BLIND | GERONTOLOGY | POLYUNSATURATED FATTY-ACIDS | PLACEBO-CONTROLLED TRIAL | ASSOCIATION | Humans | Middle Aged | Male | Perilla frutescens | Oils, Volatile - therapeutic use | Psychiatric Status Rating Scales | Animals | Iran | Fishes | Adult | Depressive Disorder - therapy | Diet Therapy - methods | Female | Aged | Plant Extracts - therapeutic use | Fish as food | Fatty acids | Depression, Mental | Statistical analysis | Mental disorders | Essential oils | Fish | Mental depression | Health risk assessment | Geriatrics
Journal Article
Techniques in Vascular and Interventional Radiology, ISSN 1089-2516, 2014, Volume 17, Issue 3, pp. 221 - 224
Critical limb ischemia (CLI) is the most severe form of peripheral arterial disease and is associated with a significant risk of limb loss. It is currently...
Radiology | Hematology, Oncology and Palliative Medicine | controlled randomized trial | critical limb ischemia | surgical bypass | endovascular therapy | Controlled randomized trial | Endovascular therapy | Critical limb ischemia | Surgical bypass | Outcome Assessment (Health Care) - methods | Prevalence | Ischemia - epidemiology | Humans | Risk Factors | Ischemia - therapy | Patient Care Team | Treatment Outcome | Ischemia - diagnosis | Peripheral Arterial Disease - therapy | Radiography | Extremities - blood supply | Outcome Assessment (Health Care) - statistics & numerical data | Peripheral Arterial Disease - diagnosis | Peripheral Arterial Disease - epidemiology | Extremities - diagnostic imaging | Clinical trials | Medicine, Experimental | Medical research | Care and treatment | Ischemia | Health aspects
Radiology | Hematology, Oncology and Palliative Medicine | controlled randomized trial | critical limb ischemia | surgical bypass | endovascular therapy | Controlled randomized trial | Endovascular therapy | Critical limb ischemia | Surgical bypass | Outcome Assessment (Health Care) - methods | Prevalence | Ischemia - epidemiology | Humans | Risk Factors | Ischemia - therapy | Patient Care Team | Treatment Outcome | Ischemia - diagnosis | Peripheral Arterial Disease - therapy | Radiography | Extremities - blood supply | Outcome Assessment (Health Care) - statistics & numerical data | Peripheral Arterial Disease - diagnosis | Peripheral Arterial Disease - epidemiology | Extremities - diagnostic imaging | Clinical trials | Medicine, Experimental | Medical research | Care and treatment | Ischemia | Health aspects
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2011, Volume 95, Issue 6, pp. 1928 - 1931
Objective To evaluate the efficacy and safety of low-dose oral contraceptives (IKH-01; 0.035 mg ethinyl estradiol and 1 mg norethisterone) for patients with...
Internal Medicine | Obstetrics and Gynecology | Oral contraceptives | primary dysmenorrhea | placebo-controlled randomized trial | REPRODUCTIVE BIOLOGY | MANAGEMENT | THERAPY | ENDOMETRIOSIS | OBSTETRICS & GYNECOLOGY | Double-Blind Method | Tablets | Dysmenorrhea - drug therapy | Humans | Japan | Treatment Outcome | Norethindrone - administration & dosage | Contraceptives, Oral, Combined - adverse effects | Dose-Response Relationship, Drug | Young Adult | Ethinyl Estradiol - adverse effects | Algorithms | Norethindrone - adverse effects | Contraceptives, Oral - administration & dosage | Placebos | Adult | Female | Contraceptives, Oral - adverse effects | Ethinyl Estradiol - administration & dosage | Contraceptives, Oral, Combined - administration & dosage | Norethindrone | Analysis | Clinical trials | Ethinyl estradiol | Dosage and administration | Dysmenorrhea
Internal Medicine | Obstetrics and Gynecology | Oral contraceptives | primary dysmenorrhea | placebo-controlled randomized trial | REPRODUCTIVE BIOLOGY | MANAGEMENT | THERAPY | ENDOMETRIOSIS | OBSTETRICS & GYNECOLOGY | Double-Blind Method | Tablets | Dysmenorrhea - drug therapy | Humans | Japan | Treatment Outcome | Norethindrone - administration & dosage | Contraceptives, Oral, Combined - adverse effects | Dose-Response Relationship, Drug | Young Adult | Ethinyl Estradiol - adverse effects | Algorithms | Norethindrone - adverse effects | Contraceptives, Oral - administration & dosage | Placebos | Adult | Female | Contraceptives, Oral - adverse effects | Ethinyl Estradiol - administration & dosage | Contraceptives, Oral, Combined - administration & dosage | Norethindrone | Analysis | Clinical trials | Ethinyl estradiol | Dosage and administration | Dysmenorrhea
Journal Article
Diabetologia, ISSN 0012-186X, 1/2012, Volume 55, Issue 1, pp. 36 - 45
Conflicting data regarding cardiovascular effects of thiazolidinediones (TZDs) and extra-skeletal effects of vitamin D supported the need for a definitive...
Type 2 diabetes | Placebo-controlled randomised trial | Medicine & Public Health | Human Physiology | Vitamin D | Pioglitazone | Metabolic Diseases | Rosiglitazone | Internal Medicine | Cardiovascular disease | Placebocontrolled randomised trial | INTIMA-MEDIA THICKNESS | GLYCEMIC CONTROL | MYOCARDIAL-INFARCTION | D SUPPLEMENTATION | HEART-FAILURE | IMPAIRED GLUCOSE-TOLERANCE | RISK | FASTING GLUCOSE | ENDOCRINOLOGY & METABOLISM | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Diabetes Mellitus, Type 2 - diet therapy | Male | Neoplasms - prevention & control | Thiazolidinediones - administration & dosage | Incidence | Dose-Response Relationship, Drug | Early Termination of Clinical Trials | Neoplasms - complications | Cardiovascular Diseases - complications | Thiazolidinediones - therapeutic use | Hypoglycemic Agents - administration & dosage | Cholecalciferol - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Cholecalciferol - adverse effects | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Risk Factors | Combined Modality Therapy | Thiazolidinediones - adverse effects | Aged | Diabetes Mellitus, Type 2 - drug therapy | Dietary Supplements | Hypoglycemic Agents - adverse effects | Neoplasms - epidemiology | Analysis | Regulatory compliance | Clinical trials | Calcifediol | Alfacalcidol | Diabetes | Health aspects | Risk factors | Glucose metabolism | Glucose | Thiazolidinediones | Dextrose
Type 2 diabetes | Placebo-controlled randomised trial | Medicine & Public Health | Human Physiology | Vitamin D | Pioglitazone | Metabolic Diseases | Rosiglitazone | Internal Medicine | Cardiovascular disease | Placebocontrolled randomised trial | INTIMA-MEDIA THICKNESS | GLYCEMIC CONTROL | MYOCARDIAL-INFARCTION | D SUPPLEMENTATION | HEART-FAILURE | IMPAIRED GLUCOSE-TOLERANCE | RISK | FASTING GLUCOSE | ENDOCRINOLOGY & METABOLISM | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Diabetes Mellitus, Type 2 - diet therapy | Male | Neoplasms - prevention & control | Thiazolidinediones - administration & dosage | Incidence | Dose-Response Relationship, Drug | Early Termination of Clinical Trials | Neoplasms - complications | Cardiovascular Diseases - complications | Thiazolidinediones - therapeutic use | Hypoglycemic Agents - administration & dosage | Cholecalciferol - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Cholecalciferol - adverse effects | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Risk Factors | Combined Modality Therapy | Thiazolidinediones - adverse effects | Aged | Diabetes Mellitus, Type 2 - drug therapy | Dietary Supplements | Hypoglycemic Agents - adverse effects | Neoplasms - epidemiology | Analysis | Regulatory compliance | Clinical trials | Calcifediol | Alfacalcidol | Diabetes | Health aspects | Risk factors | Glucose metabolism | Glucose | Thiazolidinediones | Dextrose
Journal Article